Mammographic breast density as a biomarker of effects of isoflavones on the female breast

AUTOR(ES)

Atkinson, Charlotte

FONTE

BioMed Central

RESUMO

Isoflavones possess both estrogenic and anti-estrogenic actions, and are hypothesized to protect against breast cancer. However, two intervention studies of markers of proliferation on breast tissue have raised concerns that soy isoflavones may have an estrogenic effect on breast tissue. Increased mammographic breast density is associated with an elevated risk of breast cancer, although the mechanism underlying this relationship has not been explained. Estrogens increase and anti-estrogens decrease breast density. Breast density may therefore serve as a biomarker of estrogenic or anti-estrogenic effects of a treatment on breast tissue. The effect of isoflavones on breast density is under investigation.

Documentos Relacionados

• Red clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]
• Various Doses of Soy Isoflavones Do Not Modify Mammographic Density in Postmenopausal Women12
• Physiologic effects of steroid hormones and postmenopausal hormone replacement on the female breast and breast cancer risk.
• Genetic determinants of mammographic density
• Effects of isoflavones on the skin of postmenopausal women: a pilot study